Nikola Company rang the Nasdaq Closing Bell remotely from internationally.Supply: The NasdaqTake a look at the businesses making headlines noon on
Nikola Company rang the Nasdaq Closing Bell remotely from internationally.
Supply: The Nasdaq
Take a look at the businesses making headlines noon on Monday:
Nikola — Shares of the electric-vehicle maker rose practically 6% after a JPMorgan analyst mentioned he sees a “much less drama-filled” information circulation for the corporate in 2021. “We count on Nikola to submit a video of a functioning Tre in January. We search for a gentle circulation of updates for the truck in 2021, as check milestones are met,” the analyst mentioned.
Myovant Sciences — Shares rose 25% after the corporate agreed to a collaboration with Pfizer to develop prostate most cancers drug relugolix. The drug can also be being explored for attainable use in ladies’s well being.
Weibo — The inventory dropped greater than 10% regardless of a better-than-expected quarterly report from the Chinese language social media firm. Weibo posted adjusted revenue of 66 cents per share, 6 cents above Refinitiv estimates. Its income additionally got here in above analyst forecasts. Some analysts flagged the slowdown within the firm’s progress in common lively every day customers, nonetheless.
Astrazeneca — U.S.-listed shares of the drug maker gained greater than 1% after a number of studies mentioned that the corporate’s Covid vaccine, which was developed in partnership with Oxford College, is predicted to be authorised within the U.Ok. this week. The AstraZeneca shot would probably be rolled out subsequent week if authorised within the subsequent few days.
Apple — Shares of the tech big superior greater than 3% amid power in Large Tech. The advance comes after Apple posted its fourth straight week of features.
Novavax — Shares dipped greater than 2% after the biotechnology firm mentioned its coronavirus vaccine candidate entered a Section Three trial within the U.S. and Mexico. “This trial is a important step in constructing the worldwide portfolio of secure and efficient vaccines to guard the world’s inhabitants,” mentioned CEO Stanley Erck in a press release.
DoorDash — The meals supply firm fell 3.8% after a Wall Avenue Journal column highlighted how a brand new invoice in California may damage supply providers. The regulation would require companies to have said agreements with eating places, doubtlessly hurting the expansion technique for some providers.
CNBC’s Pippa Stevens, Jesse Pound and Yun Li contributed to this report.